Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Mimedx Group Inc (NASDAQ: MDXG) closed at $7.54 in the last session, down -2.20% from day before closing price of $7.71. In other words, the price has decreased by -$2.20 from its previous closing price. On the day, 1.13 million shares were traded. MDXG stock price reached its highest trading level at $7.66 during the session, while it also had its lowest trading level at $7.5.
Ratios:
We take a closer look at MDXG’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.44. For the most recent quarter (mrq), Quick Ratio is recorded 3.95 and its Current Ratio is at 4.41. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 02, 2024, initiated with a Overweight rating and assigned the stock a target price of $11.
On March 07, 2024, Lake Street started tracking the stock assigning a Buy rating and target price of $12.
On October 27, 2023, Craig Hallum started tracking the stock assigning a Buy rating and target price of $12.Craig Hallum initiated its Buy rating on October 27, 2023, with a $12 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 06 ’25 when Maersk-Moller Kimberly sold 58,300 shares for $7.42 per share. The transaction valued at 432,329 led to the insider holds 236,982 shares of the business.
Kimberly Ann Maersk-Moller bought 68,587 shares of MDXG for $502,743 on Nov 06 ’25. On May 02 ’25, another insider, Capper Joseph H, who serves as the Chief Executive Officer of the company, bought 200,000 shares for $6.34 each. As a result, the insider paid 1,268,000 and bolstered with 529,530 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDXG now has a Market Capitalization of 1116690304 and an Enterprise Value of 992821248. As of this moment, Mimedx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 27.62, and their Forward P/E ratio for the next fiscal year is 21.70. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.11. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.84 while its Price-to-Book (P/B) ratio in mrq is 4.67. Its current Enterprise Value per Revenue stands at 2.523 whereas that against EBITDA is 14.471.
Stock Price History:
The Beta on a monthly basis for MDXG is 1.63, which has changed by 0.032128572 over the last 52 weeks, in comparison to a change of 0.14151978 over the same period for the S&P500. Over the past 52 weeks, MDXG has reached a high of $10.14, while it has fallen to a 52-week low of $5.79. The 50-Day Moving Average of the stock is 6.94%, while the 200-Day Moving Average is calculated to be 5.63%.
Shares Statistics:
According to the various share statistics, MDXG traded on average about 731.29K shares per day over the past 3-months and 1666580 shares per day over the past 10 days. A total of 148.08M shares are outstanding, with a floating share count of 116.57M. Insiders hold about 21.29% of the company’s shares, while institutions hold 50.75% stake in the company. Shares short for MDXG as of 1761868800 were 4474566 with a Short Ratio of 6.57, compared to 1759190400 on 4724384. Therefore, it implies a Short% of Shares Outstanding of 4474566 and a Short% of Float of 3.7800000000000002.
Earnings Estimates
The dynamic stock of Mimedx Group Inc (MDXG) is currently attracting attention from 2.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.08, with high estimates of $0.08 and low estimates of $0.08.
Analysts are recommending an EPS of between $0.45 and $0.4 for the fiscal current year, implying an average EPS of $0.43. EPS for the following year is $0.33, with 1.0 analysts recommending between $0.33 and $0.33.
Revenue Estimates
According to 5 analysts,. The current quarter’s revenue is expected to be $106.93M. It ranges from a high estimate of $111M to a low estimate of $99.5M. As of. The current estimate, Mimedx Group Inc’s year-ago sales were $92.91MFor the next quarter, 5 analysts are estimating revenue of $95M. There is a high estimate of $102.5M for the next quarter, whereas the lowest estimate is $82M.
A total of 5 analysts have provided revenue estimates for MDXG’s current fiscal year. The highest revenue estimate was $411.6M, while the lowest revenue estimate was $400M, resulting in an average revenue estimate of $407.48M. In the same quarter a year ago, actual revenue was $348.88MBased on 5 analysts’ estimates, the company’s revenue will be $416.08M in the next fiscal year. The high estimate is $464.9M and the low estimate is $378M.
